Apellis is acquired by Biogen, and Aspaveli receives approval in the European Union.
3 reports, 2 independent
Updated Oct 19
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Apellis is acquired by Biogen, and Aspaveli receives approval in the European Union.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Sobi presented abstracts for Aspaveli/Empaveli at ASN Kidney Week 2026 in Colorado.1 source
Biogen acquires Apellis while Aspaveli is approved in the EU.1 source
Keep exploring
The entities involved
-
sobi
German beverage store chain
Nothing else this week.
-
Biogen
American multinational biotechnology company